Chavalitdhamrong Disaya, DiMaio Christopher J, Siersema Peter D, Wagh Mihir S
Division of Gastroenterology, University of Florida, Gainesville, Florida, United States.
Division of Gastroenterology, Mount Sinai School of Medicine, New York, New York, United States.
Endosc Int Open. 2015 Aug;3(4):E373-7. doi: 10.1055/s-0034-1392274. Epub 2015 Jul 21.
Radiation therapy has an important role in the treatment of locally advanced or metastatic pancreatic cancer and can be used alone or in conjunction with surgery and/or systemic chemotherapy. Because of the challenge of delivering an accurate and optimal radiation dose, image-guided radiation therapy can be used to improve targeting. Fiducial markers can be placed in the tumor and used for localization in patients undergoing image-guided radiation therapy. The safety and feasibility of endoscopic ultrasound (EUS)-guided placement of fiducials has been assessed and reported for the management of pancreatic cancer. We herein review the technique, efficacy, and safety profile of EUS-guided fiducial placement. In addition, we highlight recent advances and technological upgrades in EUS-guided fiducial delivery systems for pancreatic cancer most relevant to practicing gastroenterologists and interventional endoscopists.
放射治疗在局部晚期或转移性胰腺癌的治疗中具有重要作用,可单独使用,也可与手术和/或全身化疗联合使用。由于精确和优化放射剂量存在挑战,图像引导放射治疗可用于改善靶向性。可在肿瘤中放置基准标记物,并用于接受图像引导放射治疗患者的定位。内镜超声(EUS)引导下放置基准标记物用于胰腺癌治疗的安全性和可行性已得到评估和报道。我们在此回顾EUS引导下放置基准标记物的技术、疗效和安全性概况。此外,我们重点介绍与胃肠病学医生和介入内镜医生密切相关的EUS引导下胰腺癌基准标记物递送系统的最新进展和技术升级。